Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Market Analysis and Insights: Global Targeted RNA Sequencing Market
The global Targeted RNA Sequencing market is projected to grow from US$ 2240.2 million in 2024 to US$ 7570 million by 2030, at a Compound Annual Growth Rate (CAGR) of 22.5% during the forecast period.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
Report Covers:
This report presents an overview of global market for Targeted RNA Sequencing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Targeted RNA Sequencing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Targeted RNA Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Targeted RNA Sequencing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Targeted RNA Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Targeted RNA Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Segment by Type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Targeted RNA Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted RNA Sequencing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted RNA Sequencing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted RNA Sequencing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Exome Sequencing
1.2.3 Enrichment Sequencing
1.2.4 Amplicon Sequencing
1.3 Market by Application
1.3.1 Global Targeted RNA Sequencing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted RNA Sequencing Market Perspective (2019-2030)
2.2 Global Targeted RNA Sequencing Growth Trends by Region
2.2.1 Targeted RNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted RNA Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Targeted RNA Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Targeted RNA Sequencing Market Dynamics
2.3.1 Targeted RNA Sequencing Industry Trends
2.3.2 Targeted RNA Sequencing Market Drivers
2.3.3 Targeted RNA Sequencing Market Challenges
2.3.4 Targeted RNA Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Targeted RNA Sequencing by Players
3.1.1 Global Targeted RNA Sequencing Revenue by Players (2019-2024)
3.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Targeted RNA Sequencing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Targeted RNA Sequencing Market Concentration Ratio
3.4.1 Global Targeted RNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted RNA Sequencing Revenue in 2023
3.5 Global Key Players of Targeted RNA Sequencing Head office and Area Served
3.6 Global Key Players of Targeted RNA Sequencing, Product and Application
3.7 Global Key Players of Targeted RNA Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted RNA Sequencing Breakdown Data by Type
4.1 Global Targeted RNA Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Targeted RNA Sequencing Forecasted Market Size by Type (2025-2030)
5 Targeted RNA Sequencing Breakdown Data by Application
5.1 Global Targeted RNA Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Targeted RNA Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted RNA Sequencing Market Size (2019-2030)
6.2 North America Targeted RNA Sequencing Market Size by Type
6.2.1 North America Targeted RNA Sequencing Market Size by Type (2019-2024)
6.2.2 North America Targeted RNA Sequencing Market Size by Type (2025-2030)
6.2.3 North America Targeted RNA Sequencing Market Share by Type (2019-2030)
6.3 North America Targeted RNA Sequencing Market Size by Application
6.3.1 North America Targeted RNA Sequencing Market Size by Application (2019-2024)
6.3.2 North America Targeted RNA Sequencing Market Size by Application (2025-2030)
6.3.3 North America Targeted RNA Sequencing Market Share by Application (2019-2030)
6.4 North America Targeted RNA Sequencing Market Size by Country
6.4.1 North America Targeted RNA Sequencing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Targeted RNA Sequencing Market Size by Country (2019-2024)
6.4.3 North America Targeted RNA Sequencing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Targeted RNA Sequencing Market Size (2019-2030)
7.2 Europe Targeted RNA Sequencing Market Size by Type
7.2.1 Europe Targeted RNA Sequencing Market Size by Type (2019-2024)
7.2.2 Europe Targeted RNA Sequencing Market Size by Type (2025-2030)
7.2.3 Europe Targeted RNA Sequencing Market Share by Type (2019-2030)
7.3 Europe Targeted RNA Sequencing Market Size by Application
7.3.1 Europe Targeted RNA Sequencing Market Size by Application (2019-2024)
7.3.2 Europe Targeted RNA Sequencing Market Size by Application (2025-2030)
7.3.3 Europe Targeted RNA Sequencing Market Share by Application (2019-2030)
7.4 Europe Targeted RNA Sequencing Market Size by Country
7.4.1 Europe Targeted RNA Sequencing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Targeted RNA Sequencing Market Size by Country (2019-2024)
7.4.3 Europe Targeted RNA Sequencing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Targeted RNA Sequencing Market Size (2019-2030)
8.2 China Targeted RNA Sequencing Market Size by Type
8.2.1 China Targeted RNA Sequencing Market Size by Type (2019-2024)
8.2.2 China Targeted RNA Sequencing Market Size by Type (2025-2030)
8.2.3 China Targeted RNA Sequencing Market Share by Type (2019-2030)
8.3 China Targeted RNA Sequencing Market Size by Application
8.3.1 China Targeted RNA Sequencing Market Size by Application (2019-2024)
8.3.2 China Targeted RNA Sequencing Market Size by Application (2025-2030)
8.3.3 China Targeted RNA Sequencing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Targeted RNA Sequencing Market Size (2019-2030)
9.2 Asia Targeted RNA Sequencing Market Size by Type
9.2.1 Asia Targeted RNA Sequencing Market Size by Type (2019-2024)
9.2.2 Asia Targeted RNA Sequencing Market Size by Type (2025-2030)
9.2.3 Asia Targeted RNA Sequencing Market Share by Type (2019-2030)
9.3 Asia Targeted RNA Sequencing Market Size by Application
9.3.1 Asia Targeted RNA Sequencing Market Size by Application (2019-2024)
9.3.2 Asia Targeted RNA Sequencing Market Size by Application (2025-2030)
9.3.3 Asia Targeted RNA Sequencing Market Share by Application (2019-2030)
9.4 Asia Targeted RNA Sequencing Market Size by Region
9.4.1 Asia Targeted RNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Targeted RNA Sequencing Market Size by Region (2019-2024)
9.4.3 Asia Targeted RNA Sequencing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Targeted RNA Sequencing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Targeted RNA Sequencing Introduction
11.1.4 Thermo Fisher Revenue in Targeted RNA Sequencing Business (2019-2024)
11.1.5 Thermo Fisher Recent Developments
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Targeted RNA Sequencing Introduction
11.2.4 Illumina Revenue in Targeted RNA Sequencing Business (2019-2024)
11.2.5 Illumina Recent Developments
11.3 Roche Holdings
11.3.1 Roche Holdings Company Details
11.3.2 Roche Holdings Business Overview
11.3.3 Roche Holdings Targeted RNA Sequencing Introduction
11.3.4 Roche Holdings Revenue in Targeted RNA Sequencing Business (2019-2024)
11.3.5 Roche Holdings Recent Developments
11.4 BGI
11.4.1 BGI Company Details
11.4.2 BGI Business Overview
11.4.3 BGI Targeted RNA Sequencing Introduction
11.4.4 BGI Revenue in Targeted RNA Sequencing Business (2019-2024)
11.4.5 BGI Recent Developments
11.5 Eurofins
11.5.1 Eurofins Company Details
11.5.2 Eurofins Business Overview
11.5.3 Eurofins Targeted RNA Sequencing Introduction
11.5.4 Eurofins Revenue in Targeted RNA Sequencing Business (2019-2024)
11.5.5 Eurofins Recent Developments
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Targeted RNA Sequencing Introduction
11.6.4 LabCorp Revenue in Targeted RNA Sequencing Business (2019-2024)
11.6.5 LabCorp Recent Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Targeted RNA Sequencing Introduction
11.7.4 Berry Genomics Revenue in Targeted RNA Sequencing Business (2019-2024)
11.7.5 Berry Genomics Recent Developments
11.8 Macrogen
11.8.1 Macrogen Company Details
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Targeted RNA Sequencing Introduction
11.8.4 Macrogen Revenue in Targeted RNA Sequencing Business (2019-2024)
11.8.5 Macrogen Recent Developments
11.9 GENEWIZ
11.9.1 GENEWIZ Company Details
11.9.2 GENEWIZ Business Overview
11.9.3 GENEWIZ Targeted RNA Sequencing Introduction
11.9.4 GENEWIZ Revenue in Targeted RNA Sequencing Business (2019-2024)
11.9.5 GENEWIZ Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
听
听
*If Applicable.